These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27789681)

  • 21. Oestrogen: brain ageing, cognition and neuropsychiatric disorder.
    Norbury R; Craig M; Cutter WJ; Whitehead M; Murphy DG
    J Br Menopause Soc; 2004 Sep; 10(3):118-22. PubMed ID: 15494104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural circuit dysfunction in mouse models of neurodevelopmental disorders.
    Del Pino I; Rico B; Marín O
    Curr Opin Neurobiol; 2018 Feb; 48():174-182. PubMed ID: 29329089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases.
    Wang L; Zhou K; Fu Z; Yu D; Huang H; Zang X; Mo X
    J Mol Neurosci; 2017 Mar; 61(3):379-384. PubMed ID: 28025777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epigenetic basis for autism spectrum disorder risk and oral contraceptive use.
    Strifert K
    Med Hypotheses; 2015 Dec; 85(6):1006-11. PubMed ID: 26364046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of estrogen actions in human lung cancer.
    Miki Y; Abe K; Suzuki S; Suzuki T; Sasano H
    Mol Cell Endocrinol; 2011 Jul; 340(2):168-74. PubMed ID: 21354461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF.
    Wu YC; Hill RA; Gogos A; van den Buuse M
    Neuroscience; 2013 Jun; 239():67-83. PubMed ID: 23085218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-Dependent Effects of Perinatal Inflammation on the Brain: Implication for Neuro-Psychiatric Disorders.
    Ardalan M; Chumak T; Vexler Z; Mallard C
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paternal Aging Affects Behavior in Pax6 Mutant Mice: A Gene/Environment Interaction in Understanding Neurodevelopmental Disorders.
    Yoshizaki K; Furuse T; Kimura R; Tucci V; Kaneda H; Wakana S; Osumi N
    PLoS One; 2016; 11(11):e0166665. PubMed ID: 27855195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex hormone receptors in breast cancer.
    D'Abreo N; Hindenburg AA
    Vitam Horm; 2013; 93():99-133. PubMed ID: 23810004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms.
    McGregor C; Riordan A; Thornton J
    Front Neuroendocrinol; 2017 Oct; 47():19-33. PubMed ID: 28673758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.
    Cyr M; Calon F; Morissette M; Di Paolo T
    J Psychiatry Neurosci; 2002 Jan; 27(1):12-27. PubMed ID: 11836973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane-initiated signaling of estrogen in the brain.
    Rønnekleiv OK; Malyala A; Kelly MJ
    Semin Reprod Med; 2007 May; 25(3):165-77. PubMed ID: 17447206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogens and memory in physiological and neuropathological conditions.
    Pompili A; Arnone B; Gasbarri A
    Psychoneuroendocrinology; 2012 Sep; 37(9):1379-96. PubMed ID: 22309827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestrogen as a neuroprotective hormone.
    Behl C
    Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation.
    Ibi D; Yamada K
    Int J Mol Sci; 2015 Nov; 16(12):28218-29. PubMed ID: 26633355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen, cognitive functions and emotion: an overview on humans, non-human primates and rodents in reproductive years.
    Gasbarri A; Tavares MC; Rodrigues RC; Tomaz C; Pompili A
    Rev Neurosci; 2012; 23(5-6):587-606. PubMed ID: 23096104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications.
    Torres F; Barbosa M; Maciel P
    J Med Genet; 2016 Feb; 53(2):73-90. PubMed ID: 26502893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.
    de Theije CG; Wu J; da Silva SL; Kamphuis PJ; Garssen J; Korte SM; Kraneveld AD
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S70-80. PubMed ID: 21810417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Way Forward for Mechanism-Based Therapeutics in Genetically Defined Neurodevelopmental Disorders.
    Modi ME; Sahin M
    Clin Pharmacol Ther; 2018 Oct; 104(4):603-606. PubMed ID: 30101418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.